In vivo suppression of visfatin by oral glucose uptake: Evidence for a novel incretin-like effect by glucagon-like peptide-1 (GLP-1)

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 8, 2011, Pages 2493-2501

  Bala, Margarita ^a   Martin, Josefine ^a   Kopp, Andrea ^a   Hanses, Frank ^a   Buechler, Christa ^a   Schaf̈fler, Andreas ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INCRETIN; INSULIN; MANNITOL; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; TESTOSTERONE;

ADIPOCYTE; ADULT; ANTHROPOMETRY; ARTICLE; CELL STRAIN 3T3; CONTROLLED STUDY; DIET RESTRICTION; ENZYME ACTIVATION; ENZYME BLOOD LEVEL; ENZYME INHIBITION; ENZYME REGULATION; ENZYME RELEASE; ENZYME REPRESSION; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; HUMAN; HUMAN EXPERIMENT; HYPERGLYCEMIA; IN VITRO STUDY; IN VIVO STUDY; INSULIN BLOOD LEVEL; LABORATORY TEST; LEAN BODY WEIGHT; MALE; NORMAL HUMAN; OBESITY; ORAL GLUCOSE TOLERANCE TEST; OSMOTIC STRESS; POSTPRANDIAL STATE; PRIORITY JOURNAL; SEX DIFFERENCE; WESTERN BLOTTING;

3T3-L1 CELLS; ADIPOCYTES; ADOLESCENT; ADULT; ANIMALS; BLOOD GLUCOSE; CYTOKINES; FASTING; FEMALE; GLUCAGON-LIKE PEPTIDE 1; GLUCOSE; GLUCOSE TOLERANCE TEST; GONADAL STEROID HORMONES; HUMANS; HYPOGLYCEMIC AGENTS; INCRETINS; INSULIN; MALE; MICE; MIDDLE AGED; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; SEX FACTORS; SIGNAL TRANSDUCTION; YOUNG ADULT;

EID: 79961215827     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-0342     Document Type: Article

References (38)

1. Okamoto Y, Kihara S, Funahashi T, Matsuzawa Y, Libby P 2006 Adiponectin: a key adipocytokine in metabolic syndrome. Clin Sci (Lond) 110:267-278 (Pubitemid 43341630)
2. Matsuzawa Y 2006 The metabolic syndrome and adipocytokines. FEBS Lett 580:2917-2921 (Pubitemid 43729162)
3. Otero M, Lago R, Lago F, Casanueva FF, Dieguez C, Gómez-Reino JJ, Gualillo O 2005 Leptin, from fat to inflammation: old questions and new insights. FEBS Lett 579:295-301 (Pubitemid 40092403)
4. Schäffler A, Schölmerich J, Salzberger B 2007 Adipose tissue as an immunological organ: Toll-like receptors, C1q/TNFs and CTRPs. Trends Immunol 28:393-399 (Pubitemid 47385374)
5. chäffler A, Müller-Ladner U, Schölmerich J, Büchler C 2006 Role of adipose tissue as an inflammatory organ in human diseases. Endocr Rev 27:449-467
6. Tilg H, Moschen AR 2006 Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 6:772-783 (Pubitemid 44453463)
7. Spiegelman BM, Flier JS 1996 Adipogenesis and obesity: rounding out the big picture. Cell 87:377-389 (Pubitemid 26374313)
8. Sommer G, Garten A, Petzold S, Beck-Sickinger AG, Bluher M, Stumvoll M, Fasshauer M 2008 Visfatin/PBEF/Nampt: structure, regulation and potential function of a novel adipokine. Clin Sci (Lond) 115:13-23 (Pubitemid 351930789)
9. Pilz S, Mangge H, Obermayer-Pietsch B, März W 2007 Visfatin/pre-B-cell colony-enhancing factor: a protein with various suggested functions. J Endocrinol Invest 30:138-144 (Pubitemid 46614445)
10. Sethi JK 2007 Is PBEF/visfatin/Nampt an authentic adipokine relevant to the metabolic syndrome? Curr Hypertens Rep 9:33-38 (Pubitemid 46546696)
11. Adeghate E 2008 Visfatin: structure, function and relation to diabetes mellitus and other dysfunctions. Curr Med Chem 15:1851-1862
12. Moschen AR, Gerner RR, Tilg H 2010 Pre-B cell colony enhancing factor/NAMPT/visfatin in inflammation and obesity-related disorders. Curr Pharm Des 16:1913-1920
13. Saddi-Rosa P, Oliveira CS, Giuffrida FM, Reis AF 2010 Visfatin, glucose metabolism and vascular disease: a review of evidence. Diabetol Metab Syndr 2:21
14. Fukuhara A, Matsuda M, Nishizawa M, Segawa K, Tanaka M, Kishimoto K, Matsuki Y, Murakami M, Ichisaka T, Murakami H, Watanabe E, Takagi T, Akiyoshi M, Ohtsubo T, Kihara S, Yamashita S, Makishima M, Funahashi T, Yamanaka S, Hiramatsu R, Matsuzawa Y, Shimomura I 2005 Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 307:426-430 (Pubitemid 40139988)
15. Brown JE, Onyango DJ, Ramanjaneya M, Conner AC, Patel ST, Dunmore SJ, Randeva HS 2010 Visfatin regulates insulin secretion, insulin receptor signalling and mRNA expression of diabetes-related genes in mouse pancreatic β-cells. J Mol Endocrinol 44:171-178
16. Schaffler A, Hamer OW, Dickopf J, Goetz A, Landfried K, Voelk M, Herfarth H, Kopp A, Buechler C, Scholmerich J, Brunnler T 2011 Admission visfatin levels predict pancreatic and peripancreatic necrosis in acute pancreatitis and correlate with clinical severity. Am J Gastroenterol 106:957-967
17. Filippatos TD, Randeva HS, Derdemezis CS, Elisaf MS, Mikhailidis DP 2010 Visfatin/PBEF and atherosclerosis-related diseases. Curr Vasc Pharmacol 8:12-28
18. Moschen AR, Kaser A, Enrich B, Mosheimer B, Theurl M, Niederegger H, Tilg H 2007 Visfatin, an adipocytokine with proinflammatory and immunomodulating properties. J Immunol 178:17481758
19. Stern SE, Williams K, Ferrannini E, DeFronzo RA, Bogardus C, Stern MP 2005 Identification of individuals with insulin resistance using routine clinical measurements. Diabetes 54:333-339
20. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC 1985 Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419 (Pubitemid 15018832)
21. Green H, Kehinde O 1975 An established preadipose cell line and its differentiation in culture. II. Factors affecting the adipose conversion. Cell 5:19-27
22. Zaitsu H, Serrero G 1990 Pedersen fetuin contains three adipogenic factors with distinct biochemical characteristics. J Cell Physiol 144:485-491
23. Bachmeier M, Löffler G 1994 Adipogenic activities in commercial preparations of fetuin. Horm Metab Res 26:92-96 (Pubitemid 24089217)
24. Green H, Kehinde O 1979 Formation of normally differentiated subcutaneous fat pads by an established preadipose cell line. J Cell Physiol 101:169-171 (Pubitemid 10196616)
25. Green H, Meuth M 1974 An established pre-adipose cell line and its differentiation in culture. Cell 3:127-133
26. Cornelius P, MacDougald OA, Lane MD 1994 Regulation of adipocyte development. Annu Rev Nutr 14:99-129 (Pubitemid 24261832)
27. MacDougald OA, Lane MD 1995 Transcriptional regulation of gene expression during adipocyte differentiation. Annu Rev Biochem 64:345-373
28. Hofsø D, Ueland T, Hager H, Jenssen T, Bollerslev J, Godang K, Aukrust P, Røislien J, Hjelmesaeth J 2009 Inflammatory mediators in morbidly obese subjects: associations with glucose abnormalities and changes after oral glucose. Eur J Endocrinol 161:451-458
29. Marcinkowska M, Lewandowski KC, Lewiñski A, Bieñkiewicz M, Basiñska-Lewandowska M, Salata I, Randeva HS 2007 Visfatin levels do not change after the oral glucose tolerance test and after a dexamethasone-induced increase in insulin resistance in humans. Endokrynol Pol 58:188-194
30. Unluturk U, Harmanci A, Yildiz BO, Bayraktar M Dynamics of Nampt/visfatin and high molecular weight adiponectin in response to oral glucose load in obese and lean women. Clin Endocrinol (Oxf) 72:469-474
31. Haider DG, Schaller G, Kapiotis S, Maier C, Luger A, Wolzt M 2006 The release of the adipocytokine visfatin is regulated by glucose and insulin. Diabetologia 49:1909-1914 (Pubitemid 44025046)
32. MacLaren R, Cui W, Cianflone K 2007 Visfatin expression is hormonally regulated by metabolic and sex hormones in 3T3-L1 preadipocytes and adipocytes. Diabetes Obes Metab 9:490-497 (Pubitemid 47018512)
33. Kralisch S, Klein J, Lossner U, Bluher M, Paschke R, Stumvoll M, Fasshauer M 2005 Hormonal regulation of the novel adipocytokine visfatin in 3T3-L1 adipocytes. J Endocrinol 185:R1-R8 (Pubitemid 40883404)
34. Dandona P, Ghanim H, Bandyopadhyay A, Korzeniewski K, Ling Sia C, Dhindsa S, Chaudhuri A 2010 Insulin suppresses endotoxin-induced oxidative, nitrosative, and inflammatory stress in humans. Diabetes Care 33:2416-2423
35. Creutzfeldt W 1992 Entero-insular axis and diabetes mellitus. Horm Metab Res Suppl 26:13-18 (Pubitemid 23017858)
36. Li L, Yang G, Li Q, Tan X, Liu H, Tang Y, Boden G 2008 Exenatide prevents fat-induced insulin resistance and raises adiponectin expression and plasma levels. Diabetes Obes Metab 10:921-930
37. Majumdar ID, Weber HC 2010 Gastrointestinal regulatory peptides and their effects on fat tissue. Curr Opin Endocrinol Diabetes Obes 17:51-56
38. Gao H, Wang X, Zhang Z, Yang Y, Yang J, Li X, Ning G 2007 GLP-1amplifies insulin signaling by up-regulation of IRβ, IRS-1 and Glut4 in 3T3-L1 adipocytes. Endocrine 32:90-95 (Pubitemid 350242552)